Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients
Launched by UNIVERSITY OF SAO PAULO · Apr 5, 2015
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
The Renal Transplant Unit, performs about 230 kidney transplants per year and has a screening service for registration of candidates for renal transplantation, interviewing about 70 patients a month. Since the potential and likely benefits of extracorporeal shock wave therapy in these patients as well as the anticipation of mild side effects, there is no reason for refusal to participate in the study.
Patients who meet the inclusion criteria will be divided into 2 groups using a randomization table created by computer. Patients will be followed for 2 years.
The study procedure and monitor...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male patients between 40 and 70 years
- • Kidney transplant for at least 6 months
- • Erectile dysfunction (ED) for at least 6 months.
- • Patients with IIEF score \<21
- • Functioning kidney graft.
- Exclusion Criteria:
- • ED because of known endocrine disease (e.g., hypogonadism, hypothyroidism)
- • ED due to drug treatment (androgen deprivation therapy, for example)
- • ED due to neurological disease (spinal cord injury, for example)
- • ED due to structural abnormality of the penis
- • History of radical prostatectomy or other pelvic surgery
- • History of pelvic irradiation
- • penile implant
- • coagulopathies or on anticoagulants
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials